Understanding Depression and Cognitive Dysfunction After A Diagnosis of TM, NMO, and ADEM
April 13, 2015
2015 ASK THE EXPERT PODCAST SERIES SPONSORED BY
Chugai Pharmaceutical Co, Ltd is conducting clinical studies to create original and innovative drugs, both in the USA and overseas, to address unmet medical needs in neurological disorders, where the level of pharmaceutical contribution and satisfaction concerning patient treatment remains low.
* The Executive Committee of SRNA with the medical and scientific council determines the content and topics of the podcasts. Sponsors are not able to influence the education program.
LISTEN & SUBSCRIBE ON ITUNES
DOWNLOAD MP3
About Our Guest Speakers
Dr. Lana Harder
Assistant Professor at UT Southwestern Medical Center, Department of Psychiatry, Neurology and Neurotherapeutics, Dallas, TX
Dr. Lana Harder completed her doctoral training at the University of Texas in Austin, Texas and completed her pre-doctoral internship at the Kennedy Krieger Institute and Johns Hopkins School of Medicine in Baltimore, Maryland. She completed her post-doctoral fellowship in Pediatric Neuropsychology at Texas Children’s Hospital and Baylor College of Medicine in Houston, Texas. Since 2008, Dr. Harder has served as a Clinical Neuropsychologist at Children’s Medical Center Dallas (CMCD) and as Assistant Professor of Psychiatry and Assistant Professor of Neurology and Neurotherapeutics at the University of Texas Southwestern Medical Center. She is board certified in Clinical Neuropsychology and specializes in the neuropsychological evaluation of pediatric patients, from infancy to young adults, with disorders of the central nervous system. Dr. Harder serves as the neuropsychologist for the CMCD Pediatric Demyelinating Diseases Clinic. Research interests include cognitive and psychosocial outcomes for pediatric multiple sclerosis (MS), transverse myelitis (TM), acute disseminated encephalomyelitis (ADEM), clinically isolated syndrome (CIS), and neuromyelitis optica (NMO).
Dr. Adam Kaplin
Assistant Professor of Psychiatry and Neurology and Chief Psychiatric Consultant at the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital, Baltimore, MD
Adam Kaplin, MD, PhD is the Principle Psychiatric Consultant to the Johns Hopkins Multiple Sclerosis and Transverse Myelitis Centers of Excellence. He is a Yale Undergraduate and Johns Hopkins School of Medicine trained Neuropsychiatrist who runs the MS and TM Neuropsychiatric Consultation Clinic, does research on the biological basis of mood disorders and cognitive impairment in CNS autoimmune disorders, and investigates novel therapies for patients suffering from CNS autoimmune diseases. He also works at Johns Hopkins to develop and improve technological innovations to enhance psychiatric care and decrease stigma surrounding mental illness.
